06/21/2024
3:15 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:16 PM | Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:17 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:18 PM | Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:19 PM | Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:45 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/14/2024
7:40 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
7:35 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024
3:15 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2024
3:16 PM | Aprea Therapeutics (Issuer)
Mirza Nadeem Q. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
6:34 AM | Aprea Therapeutics (Filer)
| Form 424B3 | |
04/29/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
04/25/2024
6:30 AM | Aprea Therapeutics (Filer)
| Form ARS | |
04/25/2024
6:15 AM | Aprea Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:00 AM | Aprea Therapeutics (Filer)
| Form DEF 14A | |
04/10/2024
3:15 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
4:59 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
4:57 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
7:15 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
6:45 AM | Aprea Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
7:51 PM | Aprea Therapeutics (Issuer)
Gilad Oren (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:52 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:53 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
7:54 PM | Aprea Therapeutics (Issuer)
Hamill John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:31 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:00 AM | Aprea Therapeutics (Subject)
Sio Capital Management, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:55 PM | Aprea Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/06/2024
4:01 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2024
11:15 PM | Aprea Therapeutics (Filer)
| Form EFFECT | |
01/26/2024
6:13 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
5:03 AM | Aprea Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
3:16 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
3:20 PM | Aprea Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/16/2023
4:29 PM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2023
6:31 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
7:30 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
8:50 PM | Aprea Therapeutics (Issuer)
Peters Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:51 PM | Aprea Therapeutics (Issuer)
HENNEMAN JOHN B III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:51 PM | Aprea Therapeutics (Issuer)
Grissinger Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:52 PM | Aprea Therapeutics (Issuer)
Pamukcu Rifat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
We’re in a code red crisis and 99% of Americans are clueless (Ad) Folks, it's 2024…
Things that we used to rely on - are failing us.
Take the phasing out of fossil fuels…
Matched with the destruction of oil refineries around the world…
And the outright failure of solar and wind technologies…
But there is just one solution…
And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!  And how YOU can prepare for the next 2024 BOOM here! |
08/24/2023
8:45 PM | Aprea Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/24/2023
8:47 PM | Aprea Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:48 PM | Aprea Therapeutics (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
8:50 PM | Aprea Therapeutics (Issuer)
Duey Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
7:00 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:36 AM | Aprea Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:39 AM | Aprea Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
